Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoantibody-mediated atherosclerosis.

Eiji Matsuura1, Kazuko Kobayashi, Takao Koike

  • 1Department of Cell Chemistry, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan. eijimatu@md.okayama-u.ac.jp

Autoimmunity Reviews
|July 10, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HTLV-1-Infected CD4<sup>+</sup> T Cells Drive Spontaneous Lymphoproliferation and Virus-Specific CD8<sup>+</sup> Cytotoxic T Lymphocyte Expansion in HAM/TSP.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Biallelic variants in FAT3 cause axonal neuropathy with multisystem neurodevelopmental features.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Comprehensive Review of Antiphospholipid Syndrome: Over Four Decades of Advances and Challenges.

Cells·2026
Same author

The regulatory roles of Beta-2 glycoprotein I (β2GPI) in thrombosis and hemostasis and abnormal disease conditions developed by autoantibodies against β2GPI.

Autoimmunity reviews·2026
Same author

Preventive Effectiveness of Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients Treated with Janus Kinase Inhibitors.

Internal medicine (Tokyo, Japan)·2025
Same author

Retraction notice to "IDF23-0574 Role of urinary HO, 8-iso-PGF2a, and serum oxLDL/ß2GP1 complex in the diabetic kidney disease." [PLoS One 17(4) (2022) e0263113].

Diabetes research and clinical practice·2025

Antiphospholipid syndrome (APS) involves beta2-glycoprotein I (beta2-GPI) and oxidized low-density lipoprotein (oxLDL). New findings suggest a link between beta2-GPI, oxLDL, and autoimmune-driven atherosclerosis in APS patients.

Area of Science:

  • Immunology
  • Cardiovascular Research
  • Autoimmune Diseases

Background:

  • Beta2-glycoprotein I (beta2-GPI) is a key antigen in antiphospholipid antibodies (aPL) associated with antiphospholipid syndrome (APS).
  • Oxidized low-density lipoprotein (oxLDL) is targeted by beta2-GPI and anti-beta2-GPI autoantibodies, playing a role in autoimmune responses.
  • Specific ligands from oxLDL, like oxLig-1, interact with beta2-GPI.

Purpose of the Study:

  • To investigate the role of beta2-GPI and oxLDL interaction in autoimmune atherogenesis.
  • To explore the mechanism of autoantibody-mediated atherosclerosis in APS.
  • To identify potential biomarkers for thrombosis in APS patients.

Main Methods:

  • Characterization of oxLDL-derived ligands binding to beta2-GPI.

Related Experiment Videos

  • In vitro studies of liposome binding to macrophages mediated by beta2-GPI and autoantibodies.
  • Detection of autoantibodies against beta2-GPI and oxLig-1 complexes in APS patient sera.

    • Main Results:

    • Oxidized ligands (oxLig-1) bind to beta2-GPI, enhancing liposome interaction with macrophages via Fcgamma receptors.
    • Autoantibodies against the beta2-GPI/oxLig-1 complex are found in APS patients.
    • The presence of these autoantibodies correlates with thrombotic events, particularly arterial thrombosis.

    Conclusions:

    • A novel mechanism of autoantibody-mediated atherosclerosis involving beta2-GPI and oxLDL is proposed for APS.
    • Autoimmune atherogenesis linked to beta2-GPI and oxLDL interactions may contribute to thrombosis in APS.
    • Autoantibodies against the beta2-GPI/oxLig-1 complex could serve as indicators for thrombotic risk in APS.